Nutriband Inc. (NTRBW)
2.26
-0.84 (-27.10%)
At close: Mar 03, 2025, 2:52 PM
2.26
0.00%
After-hours: Mar 03, 2025, 02:53 PM EST
No 1D chart data available
| Bid | 2.01 |
| Market Cap | 58.86M |
| Revenue (ttm) | 3.86M |
| Net Income (ttm) | -13.07M |
| EPS (ttm) | -0.505 |
| PE Ratio (ttm) | -4.48 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 2.51 |
| Volume | 21,982 |
| Avg. Volume (20D) | 9,737 |
| Open | 2.75 |
| Previous Close | 3.10 |
| Day's Range | 2.23 - 3.73 |
| 52-Week Range | 0.19 - 5.25 |
| Beta | 0.32 |
About NTRBW
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain. The company has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices. Nutriband Inc. was incorporated...
Industry Biotechnology
Sector Healthcare
IPO Date Oct 1, 2021
Employees 3
Stock Exchange NASDAQ
Ticker Symbol NTRBW
Website http://nutriband.com